ALNY vs UNP · P/E 76, rev $1.29B vs P/E 21, rev $6.86B
Alnylam Pharmaceuticals Inc (ALNY) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the ALNY and UNP stock pages for the full models.
Not investment advice.